| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K04800985 |
| PharmacoGx | BRD-K04800985 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NMRAL1 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | DEFB136 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.03 |
| mRNA | ARL6IP5 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | ZFHX2 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.03 |
| mRNA | C7orf50 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | CCDC107 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | GGACT | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | PRPF40A | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | SLC39A3 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.03 |
| mRNA | CSMD1 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
